Evidence map›Paper›PMID 38950721›Full record

ReviewCurrent problems in cardiology2024

Omega-3 fatty acids in the treatment of heart failure.

Matthew Kelling, Michelle Dimza, Alec Bartlett, Dmitry O Traktuev, Julio D Duarte, Ellen C Keeley

Abstract readReview
In one paragraph

Review in Current problems in cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Frontiers in pharmacology · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew KellingDepartment of Medicine, University of Florida, Gainesville, Florida; Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida.
Michelle DimzaDepartment of Medicine, University of Florida, Gainesville, Florida; Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida.
Alec BartlettDepartment of Medicine, University of Arizona, Phoenix, Arizona, United States.
Dmitry O TraktuevDepartment of Medicine, University of Florida, Gainesville, Florida; Division of Pulmonary, Critical care and Sleep Medicine, University of Florida.
Julio D DuarteDepartment of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida.
Ellen C KeeleyDepartment of Medicine, University of Florida, Gainesville, Florida; Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida. Electronic address: Ellen.Keeley@medicine.ufl.edu.

Funding

Preemptive pharmacogenetic testing in medically underserved populationsR01HG011800 · NHGRI · UNIVERSITY OF FLORIDA · PI Julio David Duarte · 2021 to 2026
$3.9M
American Heart Association-American Stroke Association 23IPA1051256NHGRI NIH HHS R01 HG011800
6 · The paper itself

Abstract

Omega-3 polyunsaturated fatty acids (Ω-3 PUFAs) have garnered increased attention as a therapeutic option in cardiovascular disease. Most of the research to date has focused on their lipid altering effects and clinical benefits in patients with coronary artery disease, however, there are data supporting their use in the treatment of heart failure. We review the mechanisms through which Ω-3 PUFAs exert their positive effects on the cardiovascular system and highlight the observational and treatment studies that assessed their effects in patients with heart failure.

Indexed as

Fatty Acids, Omega-3Heart FailureHumansTreatment OutcomeFatty Acids, Omega-3Heart failureOmega-3 fatty acidsPolyunsaturated fatty acids

Identifiers

PMID38950721
PMCPMC12817260

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.